Capital Flow Monitor · Sponsors · CIK 2017861
Endo IV Cecelia SPV, LLC
3599 HOLLYWOOD OAKS DR., FORT LAUDERDALE, FL, 33312 · 917-445-5277
Pooled Investment Fund / Venture Capital Fund · Limited Liability Company· inc. DELAWARE true 2020
Fit score
—
Offering
$591K
Sold
$591K
% sold
100.0%
Investors
23
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-05 | D ·current | 506(b) | $591K | $591K | 100.0% | 23 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Eric Edidin — Executive Officer / Director, Fort Lauderdale, FL
10 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- Illuminare Biotechnologies Inc $3.7M of $4.0M · 91.3%
- ILIAD BIOTECHNOLOGIES, INC. $115.5M of $115.5M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
- BH3 Heritage FV III Feeder L.P. $15.0M of $50.0M · 30.0%
- Endo Ventures Cecelia SPV, LLC $94K of $94K · 100.0%
- Endo G100 Cecelia SPV LLC $109K of $109K · 100.0%
- Cecelia Health Holdings, Inc. $16.1M of $19.1M · 84.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.